Kidneys from deceased donors: Maximizing the value of a scarce resource

American Journal of Transplantation

Volumn 5, Issue 7, 2005, Pages 1725-1730

  Meier Kriesche, Herwig Ulf ^a   Schold, Jesse D ^a   Gaston, Robert S ^b   Wadstrom, Jonas ^c   Kaplan, Bruce ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Age; Allocation; Deceased donor; Graft survival; Kidney transplantation; Waiting list

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CADAVER DONOR; CALCULATION; CHILD; COST BENEFIT ANALYSIS; DECEASED DONOR; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESOURCE MANAGEMENT; RISK ASSESSMENT; RISK FACTOR; SAFETY;

ADOLESCENT; ADULT; AGED; CADAVER; GRAFT SURVIVAL; HEALTH CARE RATIONING; HEALTH POLICY; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MIDDLE AGED; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTS;

EID: 21344447313     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.00923.x     Document Type: Article

References (16)

1. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
2. Oniscu GC, Brown H, Forsythe JL. How old is old for transplantation? Am J Transplant 2004; 4: 2067-2074.
3. Glanton CW, Kao TC, Cruess D, Agodoa LY, Abbott KC. Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Kidney Int 2003; 63: 647-653.
4. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 2002; 74: 1377-1381.
5. Gaston RS, Danovitch GM, Adams PL et al. The report of a national conference on the wait list for kidney transplantation. Am J Transplant 2003; 3: 775-785.
6. Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 2001; 12: 2753-2758.
7. Stratta RJ, Rohr MS, Sundberg AK et al. Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant. Ann Surg 2004; 239: 688-695. .
8. Gerstenkorn C. Non-heart-beating donors: renewed source of organs for renal transplantation during the twenty-first century. World J Surg 2003; 27: 489-493.
9. Sheehy E, Conrad SL, Brigham LE et al. Estimating the number of potential organ donors in the United States. N Engl J Med 2003; 349: 667-674.
10. Gaston RS, Ayres I, Dooley LG, Diethelm AG. Racial equity in renal transplantation. The disparate impact of HLA-based allocation. JAMA 1993; 270: 1352-1356.
11. HHS/HRSA/SPB/DOT, UNOS, URREA. OPTN/SRTR Annual Report: Transplant Data 1993-2002. 2003.
12. Yen EF, Hardinger K, Brennan DC et al. Cost-effectiveness of extending medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant 2004; 4: 1703-1708.
13. Cohen B, Smits JM, Haase B, Persijn G, Vanrenterghem Y, Fre U. Expanding the donor pool to increase renal transplantation. Nephrol Dial Transplant 2005; 20: 34-41.
14. Meier-Kriesche HU, Cibrik DM, Ojo AO et al. Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Geriatr Soc 2002; 50: 14-17.
15. Schold JD, Kaplan B, Baliga R, Meier-Kriesche HU. The broad spectrum of quality in deceased donor kidneys. Am J Transplant 2005; 5: 757-765.
16. Gaston RS, Alveranga DY, Becker BN et al. Kidney and pancreas transplantation. Am J Transplant 2003; 3: 64-77.